Portable Diagnostics MicroGEM’s focus on person-portable diagnostic devices and saliva-based PCR at point of care signals strong opportunities to upsell to healthcare providers, clinics, mobile testing services, and community health programs seeking rapid, on-site molecular testing capabilities.

Nucleic AcidTech Their enzymatic nucleic acid extraction platform enables simple, rapid sample prep, which can be bundled with downstream PCR workflows or integrated into turnkey testing kits for non-traditional settings, appealing to education, first responders, and remote healthcare sites.

Strategic Partners Existing partnerships with medline, government suppliers, and workflow service providers indicate a channel strategy worth expanding; there are expansion opportunities with distributors, healthcare IT integrators, and government procurement programs for rapid diagnostics.

Saliva PCR Advantage Saliva-based PCR for SARS-CoV-2 demonstrated at point of care provides a differentiator for public health programs, occupational health, and travel/quarantine testing, suggesting targeted outreach to employers, schools, and workplaces with screening needs.

Growth Appetite Revenue scale and recent acquisitions point to an organization open to collaboration and product line expansion; sales can pursue multi-product deals, services subscriptions, and renewal opportunities around maintenance, consumables, and integration with existing lab workflows.